Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment: 48-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study - Pozniak, A; Arribas, J R; Gathe, J; Gupta, S K; Post, F A; Bloch, M; Avihingsanon, A; Crofoot, G; Benson, P; Lichtenstein, K; Ramgopal, M; Chetchotisakd, P; Custodio, J M; Abram, M E; Wei, X; Cheng, A; McCallister, S; SenGupta, D; Fordyce, M W (J Acquir Immune Defic Syndr, 2016)